Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 300

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy

Open access
Galstyan, Anna, Markman, Janet L., Shatalova, Ekaterina S., Chiechi, Antonella, Korman, Alan J., Patil, Rameshwar, Klymyshyn, Dmytro, Tourtellotte, Warren G., Israel, Liron L., Braubach, Oliver, Ljubimov, Vladimir A., Mashouf, Leila A., Ramesh, Arshia, Grodzinski, Zachary B., Penichet, Manuel L., Black, Keith L., Holler, Eggehard, Sun, Tao, Ding, Hui, Ljubimov, Alexander V., Ljubimova, Julia Y.·2019·Nature Communications

Abstract

Brain glioma treatment with checkpoint inhibitor antibodies to cytotoxic T-lymphocyte-associated antigen 4 (a-CTLA-4) and programmed cell death-1 (a-PD-1) was largely unsuccessful due to their inability to cross blood–brain barrier (BBB). Here we describe targeted nanoscale immunoconjugates (NICs) on natural biopolymer scaffold, poly(β-L-malic acid), with covalently attached a-CTLA-4 or a-PD-1 for systemic delivery across the BBB and activation of local brain anti-tumor immune response. NIC treatment of mice bearing intracranial GL261 glioblastoma (GBM) results in an increase of CD8+ T cells, NK cells and macrophages with a decrease of regulatory T cells (Tregs) in the brain tumor area. Survival of GBM-bearing mice treated with NIC combination is significantly longer compared to animals treated with single checkpoint inhibitor-bearing NICs or free a-CTLA-4 and a-PD-1. Our study demonstrates trans-BBB delivery of tumor-targeted polymer-conjugated checkpoint inhibitors as an effective GBM treatment via activation of both systemic and local privileged brain tumor immune response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-11719-3

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Cited by

See all 300

Metadata

Authors
Galstyan, A., Markman, J. L., Shatalova, E. S., Chiechi, A., Korman, A. J., Patil, R., Klymyshyn, D., Tourtellotte, W. G., Israel, L. L., Braubach, O., Ljubimov, V. A., Mashouf, L. A., Ramesh, A., Grodzinski, Z. B., Penichet, M. L., Black, K. L., Holler, E., Sun, T., Ding, H., Ljubimov, A. V., & Ljubimova, J. Y.
Venue
Nature Communications
Published
2019-08-28
Volume
10
Issue
1
Pages
3850-3850
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2970204123
Cited by
300
References
65
FWCI
12.88
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy. https://app.cochat.ai/papers/10.1038/s41467-019-11719-3
The paper
Galstyan, A., Markman, J. L., Shatalova, E. S., Chiechi, A., Korman, A. J., Patil, R., Klymyshyn, D., Tourtellotte, W. G., Israel, L. L., Braubach, O., Ljubimov, V. A., Mashouf, L. A., Ramesh, A., Grodzinski, Z. B., Penichet, M. L., Black, K. L., Holler, E., Sun, T., Ding, H., . . . Ljubimova, J. Y. (2019). Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy. Nature Communications. https://doi.org/10.1038/s41467-019-11719-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.